3M Pharmaceuticals
Background
In the latter part of 2006, Meda announced completion its acquisition of the pharmaceutical division of 3M in Europe. [1]
At the same time, 3M announced that it had agreed to sell its pharmaceutical operations in the United States, Canada, and Latin America region to Graceway Pharmaceuticals Inc. at a cost of $875million. 3M's pharmaceutical operations in the Asia Pacific region (including Australia and South Africa) were also sold to Ironbridge Capital and Archer Capital. [2]
PR, Lobbying and Market Intelligence firms
In 2008, 3M is listed as a client of Innovex[3] and a past or current client of German PR company FischerAppelt Kommunikation[4]
Affiliations
3M Pharmaceuticals is listed as a member of the Pharmaceutical Research and Manufacturers of America (PHRMA) in 2005[5] and 2006 [6].3M is also listed as a member of the American Benefits Council[7]
References
- ↑ Zenopa Meda completes 3M Pharmaceuticals acquisition in Europe Accessed 15th December 2007
- ↑ 3M 3M Reaches Agreements to Sell its Pharmaceuticals Business Accessed 15th December 2007
- ↑ Innovex Our Customers Accessed 12th February 2008
- ↑ FischerAppelt Kommunikation Current & former clients Accessed 14th February 2008
- ↑ PHRMA 2005 Industry Profile Accessed 16th December 2007
- ↑ PHRMA 2006 Member Company List Accessed 16th December 2007
- ↑ American Benefits Council Memberships Accessed 26th February 2008